Company Filing History:
Years Active: 2014-2020
Title: Xunrong Luo: Innovator in Diabetes and Transplant Tolerance
Introduction
Xunrong Luo is a prominent inventor based in Chicago, IL, specializing in innovative methods for diagnosing and treating diabetes, as well as preventing allograft rejection. With a total of 2 patents, his work significantly contributes to the fields of medical diagnostics and transplantation.
Latest Patents
Luo's latest patents include a method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes. This invention provides epitopes and mimotopes useful in the diagnosis and treatment of type 1 diabetes (T1D), along with antibodies recognizing such epitopes, and various diagnostics, therapeutics, kits, and methods of use. Another notable patent is the use of ECDI-fixed cell tolerance as a method for preventing allograft rejection. This invention outlines methods, systems, and compositions for inducing donor-specific tolerance, particularly through the administration of ECDI-treated cells in conjunction with donor transplant cells or allografts.
Career Highlights
Xunrong Luo is affiliated with Northwestern University, where he continues to advance research in his areas of expertise. His contributions to the scientific community are recognized through his innovative patents and ongoing research efforts.
Collaborations
Luo collaborates with esteemed colleagues, including Stephen D. Miller and Jing Jin, enhancing the impact of his research through shared knowledge and expertise.
Conclusion
Xunrong Luo's innovative work in diabetes and transplant tolerance showcases his commitment to advancing medical science. His patents reflect significant advancements that have the potential to improve patient outcomes in these critical areas.